Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 936 participants.
Also called NCT02449330
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 936 participants
- Registry
-
NCT02449330
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Japan
- Registry status
- Unknown status
Technical summary
Registry record NCT02449330. Randomized; single masking; primary purpose treatment. Start 2015-06 (registry gives no type); primary completion 2020-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus Study
- Acronym
- TOPLEVEL
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Teneligliptin
- Lead sponsor
- National Cerebral and Cardiovascular Center, Japan
Record details
- Record id
cardio:ct-nct02449330- Content hash
302ca010630cec5361d77b53c950c1b7b08e4f0f8f8db71105f4c99fba3ffb4f